Market Closed -
Nyse
01:30:02 09/05/2024 am IST
|
5-day change
|
1st Jan Change
|
30.82
USD
|
+2.60%
|
|
+15.17%
|
+42.29%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,939
|
13,637
|
18,851
|
-
|
-
|
Enterprise Value (EV)
1 |
23,313
|
20,561
|
28,219
|
28,219
|
28,219
|
P/E ratio
|
1.59
x
|
12.7
x
|
6.09
x
|
5.36
x
|
4.52
x
|
Yield
|
2.29%
|
12.5%
|
3.11%
|
3.98%
|
3.84%
|
Capitalization / Revenue
|
0.72
x
|
0.64
x
|
0.8
x
|
0.76
x
|
0.75
x
|
EV / Revenue
|
1.29
x
|
0.97
x
|
1.2
x
|
1.14
x
|
1.12
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
15.7
x
|
14.1
x
|
-
|
FCF Yield
|
-
|
-
|
6.38%
|
7.09%
|
-
|
Price to Book
|
1.58
x
|
1.14
x
|
1.4
x
|
1.16
x
|
0.91
x
|
Nbr of stocks (in thousands)
|
6,45,000
|
6,29,596
|
6,11,641
|
-
|
-
|
Reference price
2 |
20.06
|
21.66
|
30.82
|
30.82
|
30.82
|
Announcement Date
|
17/02/23
|
15/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,056
|
21,212
|
23,511
|
24,802
|
25,140
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
2,544
|
3,125
|
4,131
|
4,485
|
4,461
|
Operating Margin
|
14.09%
|
14.73%
|
17.57%
|
18.08%
|
17.74%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
4,064
|
4,272
|
Net income
1 |
8,149
|
1,104
|
3,052
|
3,173
|
3,410
|
Net margin
|
45.13%
|
5.2%
|
12.98%
|
12.79%
|
13.56%
|
EPS
2 |
12.59
|
1.710
|
5.060
|
5.753
|
6.820
|
Free Cash Flow
1 |
-
|
-
|
1,800
|
2,000
|
-
|
FCF margin
|
-
|
-
|
7.66%
|
8.06%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
58.98%
|
63.03%
|
-
|
Dividend per Share
2 |
0.4600
|
2.700
|
0.9600
|
1.228
|
1.185
|
Announcement Date
|
17/02/23
|
15/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,441
|
5,369
|
5,363
|
5,845
|
4,081
|
5,923
|
5,853
|
5,742
|
5,741
|
5,949
|
6,173
|
6,289
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
549
|
706
|
-
|
945
|
909
|
798
|
786
|
1,069
|
1,122
|
1,155
|
-
|
-
|
Operating Margin
|
12.36%
|
13.15%
|
-
|
16.17%
|
22.27%
|
13.47%
|
13.43%
|
18.62%
|
19.54%
|
19.42%
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
2,351
|
-566
|
-459
|
771
|
2,101
|
-1,309
|
878
|
705.1
|
741.7
|
747.3
|
757.5
|
783
|
Net margin
|
52.94%
|
-10.54%
|
-8.56%
|
13.19%
|
51.48%
|
-22.1%
|
15%
|
12.28%
|
12.92%
|
12.56%
|
12.27%
|
12.45%
|
EPS
2 |
3.630
|
-0.8700
|
-0.7000
|
1.180
|
3.280
|
-2.070
|
1.410
|
1.147
|
1.255
|
1.301
|
1.368
|
1.420
|
Dividend per Share
2 |
0.2300
|
0.2300
|
0.2300
|
0.2300
|
0.2300
|
1.390
|
0.2300
|
0.2320
|
0.2438
|
0.2580
|
0.2600
|
0.2591
|
Announcement Date
|
09/11/22
|
17/02/23
|
09/05/23
|
04/08/23
|
03/11/23
|
15/02/24
|
03/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
10,374
|
6,924
|
9,368
|
9,368
|
9,368
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
1,800
|
2,000
|
-
|
ROE (net income / shareholders' equity)
|
9.1%
|
11.3%
|
12.2%
|
13.2%
|
13.5%
|
ROA (Net income/ Total Assets)
|
2.09%
|
-
|
25%
|
26.9%
|
-
|
Assets
1 |
3,90,222
|
-
|
12,220
|
11,774
|
-
|
Book Value Per Share
2 |
12.70
|
18.90
|
22.00
|
26.50
|
33.90
|
Cash Flow per Share
|
4.160
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
17/02/23
|
15/02/24
|
-
|
-
|
-
|
Last Close Price
30.82
USD Average target price
31.25
USD Spread / Average Target +1.40% Consensus |
1st Jan change
|
Capi.
|
---|
| +42.29% | 18.37B | | +12.85% | 77.41B | | +8.36% | 50.67B | | +2.82% | 48.12B | | +14.75% | 43.61B | | +12.52% | 41.74B | | +5.98% | 30.76B | | -2.46% | 29.21B | | -12.42% | 26.1B | | +11.26% | 23.07B |
Other Life & Health Insurance
|